PGP and breast carcinoma: The underlying mechanism of UCHL1 mediated MDR to P-glycoprotein (P-gp) substrate drugs and the increased invasion and migration in resistant breast cancer cells compared to the sensitive phenotype, which might be associated with MAPK/Erk pathway activation [74].